Inflammatory bowel disease (IBD) is a chronic inflammatory disorder characterized by
immune system dysfunction. Despite the availability of various anti-inflammatory drugs, they …

Dysfunction of the intestinal mucosal immune system and dysbiosis of the intestinal
microflora can induce inflammatory bowel disease. However, drug-mediated clinical …

Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease characterized by
rapid progression and frequent comorbidities that make its treatment challenging …

Modulation of innate immune responses is a potential strategy for treating inflammatory
diseases. Although biogenic polyamines are known as immunomodulatory compounds …

As one of the most challenging inflammatory diseases, the incidence of ulcerative colitis
(UC) is increasing year by year, but the existing therapeutic drugs are not effective and lack …

In this study, we developed oral core–shell nanoparticles composed of curcumin
nanocrystals in the core and chitosan/alginate multilayers in the shell for inflammation …

Oxidative stress is a key factor in the development of inflammatory diseases. Elimination of
reactive oxygen species (ROS) in the inflamed colon has been confirmed as an effective …

Ulcerative colitis (UC) is a severe inflammatory disease in colon, however, the therapeutic
efficacy of the standard‐of‐care in clinic for UC patients is unsatisfactory. To explore new …

Background Due to oral nano-delivery systems for the treatment of inflammatory bowel
disease (IBD) are often failed to accumulated to the colonic site and could not achieve …

Colorectal cancer is the third most common malignancy that leads to significant mortality
around the world. Chronic colonic inflammation could induce a protumor effect by the …